The Cancer Center at Cold Spring Harbor Laboratory (CSHL) is a basic research center devoted to the understanding of fundamental biology of human cancer. A principal focus of the research at the Center is to understand the molecular mechanisms that govern cell growth and cell division and how these processes are altered in human tumor cells. This cellular based research focuses mainly on key biological processes, such as gene expression, DMA replication and chromosome segregation during the cell division cycle, RNA processing, cell morphology and cell signaling mechanisms. Intertwined with the research on these fundamental cellular processes is research on the regulatory machineries that coordinate cell growth, cell cycle progression, differentiation and cell death. Increasingly, we have integrated the genetics of human cancer, both familial and sporadic, into this program of basic research, as well as increasing our emphasis on creating and using animal models of human cancer. Together, these approaches are beginning to link cancer genetics to cancer therapy. Finally, we have established a powerful informatics capability that will benefit the analysis of large databases, including those that store sequence information and those more connected to clinical databases. The Cancer Center is organized into three research Programs (Gene Expression, Cancer Genetics and Cell Biology) and eleven Shared Research Resources. Each of the research programs has a strong basic) cancer research focus, but there is increasing research that focuses on clinically important issues such as cancer genetics and cancer therapy. A notable characteristic of the research at the CSHL Cancer Center is the high degree of interactions between the individual research groups. This includes extensive interactions between research groups within programs and in different programs. The Shared Resources provide specialized, state-of-the art equipment and techniques that are available to all Cancer Center Members. These are continually updated and revised as technologies and needs change. This cohesive yet flexible organization has enabled Center investigators to perform research at the highest level, and scientific progress during the last funding period has been substantial.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA045508-23S1
Application #
7926634
Study Section
Subcommittee G - Education (NCI)
Program Officer
Marino, Michael A
Project Start
2009-09-30
Project End
2011-03-31
Budget Start
2009-09-30
Budget End
2011-03-31
Support Year
23
Fiscal Year
2009
Total Cost
$258,373
Indirect Cost
Name
Cold Spring Harbor Laboratory
Department
Type
DUNS #
065968786
City
Cold Spring Harbor
State
NY
Country
United States
Zip Code
11724
Stacchiotti, Silvia; Mir, Olivier; Le Cesne, Axel et al. (2018) Activity of Pazopanib and Trabectedin in Advanced Alveolar Soft Part Sarcoma. Oncologist 23:62-70
Banito, Ana; Li, Xiang; Laporte, Aimée N et al. (2018) The SS18-SSX Oncoprotein Hijacks KDM2B-PRC1.1 to Drive Synovial Sarcoma. Cancer Cell 33:527-541.e8
Goncalves, Marcus D; Hwang, Seo-Kyoung; Pauli, Chantal et al. (2018) Fenofibrate prevents skeletal muscle loss in mice with lung cancer. Proc Natl Acad Sci U S A 115:E743-E752
Hwang, Dong-Woo; Jaganathan, Anbalagan; Shrestha, Padmina et al. (2018) Chromatin-mediated translational control is essential for neural cell fate specification. Life Sci Alliance 1:e201700016
Knott, Simon R V; Wagenblast, Elvin; Khan, Showkhin et al. (2018) Asparagine bioavailability governs metastasis in a model of breast cancer. Nature 554:378-381
Biffi, Giulia; Oni, Tobiloba E; Spielman, Benjamin et al. (2018) IL-1-induced JAK/STAT signaling is antagonized by TGF-beta to shape CAF heterogeneity in pancreatic ductal adenocarcinoma. Cancer Discov :
Xie, Yuanyuan; Cao, Zhen; Wong, Elissa Wp et al. (2018) COP1/DET1/ETS axis regulates ERK transcriptome and sensitivity to MAPK inhibitors. J Clin Invest 128:1442-1457
Aznarez, Isabel; Nomakuchi, Tomoki T; Tetenbaum-Novatt, Jaclyn et al. (2018) Mechanism of Nonsense-Mediated mRNA Decay Stimulation by Splicing Factor SRSF1. Cell Rep 23:2186-2198
Fang, Han; Huang, Yi-Fei; Radhakrishnan, Aditya et al. (2018) Scikit-ribo Enables Accurate Estimation and Robust Modeling of Translation Dynamics at Codon Resolution. Cell Syst 6:180-191.e4
Lin, Kuan-Ting; Ma, Wai Kit; Scharner, Juergen et al. (2018) A human-specific switch of alternatively spliced AFMID isoforms contributes to TP53 mutations and tumor recurrence in hepatocellular carcinoma. Genome Res :

Showing the most recent 10 out of 380 publications